The drug is administered intravenously, typically in a clinical setting, to ensure proper dosage and to monitor for adverse reactions. The specific dosing regimen depends on the type and stage of cancer being treated, as well as the patient's overall health and response to therapy. It is critical to follow the oncologist's instructions precisely to maximize the drug's efficacy while minimizing potential side effects.